Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:147-152
doi: 10.1161/hq0102.101770
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, I. B.
Right arrow Articles by Cockcroft, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, I. B.
Right arrow Articles by Cockcroft, J. R.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Other arteriosclerosis
Right arrow Risk Factors for Stroke
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:147.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Pulse-Wave Analysis

Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function

Ian B. Wilkinson; Ian R. Hall; Helen MacCallum; Isla S. Mackenzie; Carmel M. McEniery; Bart J. van der Arend; Yae-Eun Shu; Laura S. MacKay; David J. Webb; John R. Cockcroft

From the Clinical Pharmacology Units, University of Cambridge (I.B.W., I.S.M., C.M.M.), Addenbrooke’s Hospital, Cambridge, England, and the University of Edinburgh (H.M., B.J.v.d.A., Y.-E.S., L.S.M., D.J.W.), Western General Hospital, Edinburgh, Scotland, and the Department of Cardiology (I.R.H., J.R.C.), University of Wales College of Medicine, University Hospital, Cardiff, Wales.

Correspondence to Dr I.B. Wilkinson, Clinical Pharmacology Unit, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK. E-mail ibw20{at}cam.ac.uk

Currentmethods for assessing vasomotor endothelial function are impractical for use in large studies. We tested the hypothesis that pulse-wave analysis (PWA) combined with provocative pharmacological testing might provide an alternative method. Radial artery waveforms were recorded and augmentation index (AIx) was calculated from derived aortic waveforms. Thirteen subjects received sublingual nitroglycerin (NTG), inhaled albuterol, or placebo. Twelve subjects received NTG, albuterol, and placebo separately during an infusion of NG-monomethyl-L-arginine (LNMMA) or norepinephrine. Twenty-seven hypercholesterolemic subjects and 27 controls received NTG followed by albuterol. Endothelial function was assessed by PWA and forearm blood flow in 27 subjects. Albuterol and NTG both significantly and repeatably reduced AIx (P<0.001). Only the response to albuterol was inhibited by LNMMA (-9.8±5.5% vs -4.7±2.7%; P=0.02). Baseline AIx was higher in the hypercholesterolemic subjects, who exhibited a reduced response to albuterol (P=0.02) but not to NTG when compared with matched controls. The responses to albuterol and acetylcholine were correlated (r=0.5, P=0.02). Consistent with an endothelium-dependent effect, the response to albuterol was substantially inhibited by LNMMA. Importantly, the response to albuterol was reduced in subjects with hypercholesterolemia and was correlated to that of intra-arterial acetylcholine. This methodology provides a simple, repeatable, noninvasive means of assessing endothelial function in vivo.


Key Words: hypercholesterolemia • nitric oxide • pulse-wave analysis • augmentation index • endothelial function